<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Turk J Haematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Turk J Haematol</journal-id>
      <journal-id journal-id-type="publisher-id">TJH</journal-id>
      <journal-title-group>
        <journal-title>Turkish Journal of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1300-7777</issn>
      <issn pub-type="epub">1308-5263</issn>
      <publisher>
        <publisher-name>Galenos Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27020727</article-id>
      <article-id pub-id-type="pmc">4805351</article-id>
      <article-id pub-id-type="doi">10.4274/tjh.2015.0268</article-id>
      <article-id pub-id-type="publisher-id">1607</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>An Unexpected Innocent Complication Associated with Azacitidine Treatment of Myelodysplastic Syndrome: Erythema Annulare Centrifugum</article-title>
        <trans-title-group xml:lang="tr">
          <trans-title>Miyelodisplastik Sendrom Tedavisi Seyrinde Azasitidin &#x130;li&#x15F;kili Beklenmedik Masum Komplikasyon: Eritem Annulae Santrifuj</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Turan Erkek</surname>
            <given-names>Esra</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kalayo&#x11F;lu Be&#x15F;&#x131;&#x15F;&#x131;k</surname>
            <given-names>Sevgi</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>
&#x130;stanbul University &#x130;stanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, &#x130;stanbul, Turkey
</aff>
      <author-notes>
        <corresp id="COR1">* Address for Correspondence: &#x130;stanbul University &#x130;stanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, &#x130;stanbul, Turkey E-mail: <email>dresraturan@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>2</month>
        <year>2016</year>
      </pub-date>
      <volume>33</volume>
      <issue>1</issue>
      <fpage>81</fpage>
      <lpage>82</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Turkish Journal of Hematology, Published by Galenos Publishing.&#xD;
</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Erythema annulare centrifugum</kwd>
        <kwd>Azacitidine</kwd>
        <kwd>myelodysplastic syndrome</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>TO THE EDITOR</title>
      <p>Skin lesions accompanying hematological malignancies can be formed due to either direct tumor infiltration of the skin or indirect effects. Indirectly developing lesions may be a component of paraneoplastic syndrome. Erythema annulare centrifugum (EAC) is considered to be a hypersensitivity reaction developed against various antigens associated with infections, drugs, and endocrine diseases. EAC, rarely seen in neoplastic diseases, has been reported in lymphoma, leukemia, histiocytosis, and prostate cancer. Here we report EAC in a patient using a hypomethylating agent, azacitidine.</p>
      <p>A 69-year-old female patient was admitted to our polyclinic with weakness and ecchymosis in her legs existing for 3 months. She was considered as having refractory anemia with excess blasts-2 according to myelodysplastic syndrome (MDS) classification [<xref rid="ref1" ref-type="bibr">1</xref>]. Because there was only hyperdiploidy in conventional cytogenetic examination, she was classified in group intermediate-2 of the International Prognostic Scoring System. She had a history of radical mastectomy and adjuvant chemoradiotherapy for breast cancer 3 years ago. She said that variously sized round and oval erythematous, itching, painless lesions had formed in the abdominal region on the 4th day of azacitidine usage (75 mg/m2/day, 7 days, s.c.) (<xref ref-type="fig" rid="f1">Figure 1</xref> and <xref ref-type="fig" rid="f2">2</xref>). There were no concomitant complaints or physical examination findings except fatigue. After azacitidine was stopped, a skin biopsy was taken. In the biopsy, mild perivascular inflammatory infiltration accompanying vascular ectasia in the papillary dermis was detected. The possibility of paraneoplastic syndrome was excluded due to the disappearance of all lesions by 1 week after cessation of treatment. During the second course of azacitidine, the lesions reoccurred on the second day. Subsequently to the second course, the patient died of sepsis, which developed after pneumonia.</p>
      <p>EAC was first defined by Darier in 1916, and it was classified into categories of superficial and deep forms by Ackerman in 1978 [<xref rid="ref2" ref-type="bibr">2</xref>]. In the deep form, the lesions are hard and are usually seen together with desquamation without itching. The superficial form is characterized by itchy lesions with uncertain borders and desquamation. EAC formation is associated with trauma, ectoparasites, tuberculin test, PUVA therapy (photochemotherapy), viral infections, and diabetes. There are publications reporting that EAC may be associated with Hodgkin&#x2019;s lymphoma rarely and lung, colon, cervix, prostate, stomach, and ovarian cancers even more rarely [<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref4" ref-type="bibr">4</xref>]. Lesions are often observed on the trunk, proximal portions of the limbs, and the buttocks. Today EAC is defined as a characteristic hypersensitivity reaction that can be triggered by many different antigens and disappears within 1-2 weeks.</p>
      <p>Skin lesions, whose most common forms are Sweet syndrome and myeloid sarcoma, are rarely observed in MDS [<xref rid="ref5" ref-type="bibr">5</xref>]. Azacitidine, a nucleoside analogue, is one of the low-density treatment options in MDS. Azacitidine usage may cause cutaneous reactions such as urticaria, skin dryness, nodules, localized hematoma at the injection area, rash, granuloma, swelling, pigmentation changes, and induration.</p>
      <p>This case was presented because no AEC development during azacitidine use in MDS had been reported previously.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="FN3" fn-type="con">
        <p>Concept: Sevgi Kalayo&#x11F;lu Be&#x15F;&#x131;&#x15F;&#x131;k, Design: Sevgi Kalayo&#x11F;lu Be&#x15F;&#x131;&#x15F;&#x131;k, Data Collection or Processing: Esra Turan Erkek, Sevgi Kalayo&#x11F;lu Be&#x15F;&#x131;&#x15F;&#x131;k, Analysis or Interpretation: Esra Turan Erkek, Sevgi Kalayo&#x11F;lu Be&#x15F;&#x131;&#x15F;&#x131;k, Literature Search: Esra Turan Erkek, Sevgi Kalayo&#x11F;lu Be&#x15F;&#x131;&#x15F;&#x131;k, Writing: Esra Turan Erkek.</p>
      </fn>
      <fn id="FN1" fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Vardiman</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Brunning</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>The World Health Organization (WHO) classification of the myeloid neoplasms</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>100</volume>
          <fpage>2292</fpage>
          <lpage>2302</lpage>
          <pub-id pub-id-type="pmid">12239137</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Weyers</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Diaz-Cascajo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Weyers</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Erythema annulare centrifugum: results of a clinicopathologic study of 73 patients</article-title>
          <source>Am J Dermatopathol</source>
          <year>2003</year>
          <volume>25</volume>
          <fpage>451</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="pmid">14631185</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Ural</surname>
              <given-names>AU</given-names>
            </name>
            <name>
              <surname>Ozcan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Avcu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kaptan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ta&#x15F;tan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Beyan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yal&#xE7;in</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Erythema annulare centrifugum as the presenting sign of CD 30 positive anaplastic large cell lymphoma-association with disease activity</article-title>
          <source>Haematologia (Budap)</source>
          <year>2001</year>
          <volume>31</volume>
          <fpage>81</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">11345410</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Carlesimo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fidanza</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mari</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pranteda</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Veggia</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Camplone</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Erythema annularecentrifugum associated with mantle B-cell non-Hodgkin&#x2019;s lymphoma</article-title>
          <source>Acta Derm Venereol</source>
          <year>2009</year>
          <volume>89</volume>
          <fpage>319</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">19479141</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Soppi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nousiainen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Seppa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lahtinen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Acute febrile neutrophilic dermatosis (Sweet&#x2019;s syndrome) in association with myelodysplastic syndromes: a report of three cases and a review of the literature</article-title>
          <source>Br J Haematol</source>
          <year>1989</year>
          <volume>73</volume>
          <fpage>43</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">2679862</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Erythema annulare centrifugum rashes formed during treatment.</title>
      </caption>
      <graphic xlink:href="TJH-33-81-g1"/>
    </fig>
    <fig id="f2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>Skin lesions&#x2019; regression after treatment interruption.</title>
      </caption>
      <graphic xlink:href="TJH-33-81-g2"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
